Skin & AestheticsLimited ResearchResearch OnlyC

RU-58841

RU58841

Last reviewed . First published . By the PeptIQ team.

Educational and observational reference only. Not medical advice. Community charts may use modeled aggregates when live snapshots are unavailable.

Studies cited
4
Research grade
C
Experience
81

Overall check-ins

Activity
74

Trackers & reports

Typical Dose

Varies by formulation

Route

Topical

Cycle

Protocol-dependent

Storage

Room Temperature

What is RU-58841?

Topical anti-androgen research compound discussed for hair-loss protocols (non-peptide).

Research Indications

Skin RepairEffective

Supports collagen synthesis and skin barrier function

Anti-AgingEffective

Research shows potential for reducing fine lines and improving skin texture

Wound HealingModerate

May accelerate cutaneous wound healing

Research Protocols

These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Starting DoseLow dosePer protocolVaries
Standard DoseTitratedPer protocolVaries

Peptide & Drug Interactions

Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.

Consult prescriber before combining with any medicationCaution
BPC-157Compatible
NAD+Compatible
Vitamin DCompatible

How to Apply

  1. 1

    Ensure hands and work area are clean before handling any peptide product

  2. 2

    Topical GHK-Cu products are typically pre-formulated — follow product instructions

  3. 3

    Apply a thin layer to clean, dry skin in the target area

  4. 4

    Store as directed on packaging, typically at room temperature away from direct sunlight

  5. 5

    Avoid applying to broken or irritated skin unless directed by a provider

What to Expect

Week 1–2

Initial effects and adaptation period. Monitor for any adverse reactions.

Week 2–4

Primary effects begin to manifest. Adjust dosing as recommended by your provider.

Week 4–8

Main therapeutic effects should be established. Assess progress with your provider.

Week 8+

Evaluate results and determine continuation, cycling, or dose adjustments.

Side Effects & Safety

  • Injection site reactions (redness, bruising, mild pain)
  • Potential for allergic reaction — discontinue if rash or hives occur
  • Individual reactions vary — start at the lowest dose and monitor carefully
  • Consult your healthcare provider before use and report any unusual symptoms

FDA Status & Regulatory Info

Research Only

Topical anti-androgen research compound discussed for hair-loss protocols (non-peptide).

Rx Required: No
503A Ban: No
Telehealth: N/A
Full FDA Status Tracker

Frequently Asked Questions

Community-reported data

The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.

What 376 users report

Observational self-reports (modeled when live data is unavailable). Not clinical outcomes.

376 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 70% · Mixed 18% · Unfavorable overall 12%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Joint comfort
-29
Recovery
-39
Digestive comfort
-40
Skin appearance
-107
Appetite control
-138

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Injection site reaction
-113
Anxiety
-139
Flushing
-75
Headache
-112
GI discomfort
-139

Self-reported dose per injection

Median bucket: 100–200 mcg · Most common: 100–200 mcg

Reports span 10–1000 mcg

10–25
3
25–50
5
50–100
10
100–200
20
200–400
15
400–600
9
600–1000
2

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing20stacking13side effects36ru-588419

How repeat users are trending

Among repeat reporters, 65% said they felt similar to their last entry, 32% more positive, and 20% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 24 days · Based on 83 repeat reporters

Share Your Experience

Rate RU-58841 in the PeptIQ app and help the community make informed decisions.

Research References (3)

Cited PubMed, trial registry, and label sources for education only. We do not control third-party content.

  1. PubMed

    RU 58841, a new specific topical antiandrogen: a candidate for the treatment of androgenetic alopecia

    Miyamoto H, Yeh S, Lardy H, et al. J Steroid Biochem Mol Biol. 1997

    Source
    Wiki study page →
  2. PubMed

    Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques

    Pan HJ, Wilding G, Uno H, et al. Endocrine. 1998

    Source
    Wiki study page →
  3. PubMed

    Effects of topical antiandrogen and 5-alpha-reductase inhibitors on sebaceous glands in male fuzzy rats

    Ye F, Imamura K, Imanishi N, et al. Skin pharmacology : the official journal of the Skin Pharmacology Society. 1997

    Source
    Wiki study page →

Wiki tools

Observational indexes and compare views for RU-58841.

Educational information only

This page is for educational reference. It is not medical or legal advice. PeptIQ does not sell peptides or list vendors. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.

PeptIQ app

Log your RU-58841 protocol in PeptIQ

Turn this RU-58841 guide into a living protocol — doses, vials, and history in one place.

Track RU-58841Open web app

iOS, Android, and web

Ask PeptIQ

Two taps on our guided quiz, then keep going in iMessage with sources — not Instagram screenshots.

Start the quizOr try Peptide X Quiz →

Quick Facts

Route
Topical
Availability
Research only
Rx Required
No
503A Ban
No
Browse peptide education

Talk with a clinician

PeptIQ is education only. We do not sell peptides or list vendors. Discuss RU-58841 with a licensed healthcare provider — not medical advice, not a prescription.

Download PeptIQ

Wiki tools

Observational indexes and compare views for RU-58841.